Dequalinium analogues require a linking chain of at least 5 methylene groups for optimal SKCa channel blocking activity in rat sympathetic neurones.
Answers are grounded in this paper and cite their sources.
Informs SAR-guided design of SKCa blockers; leaves open translation to cardiovascular models.
Dequalinium is a potent and selective blocker of the small conductance Ca(2+)-activated K+ (SKCa) channel in rat sympathetic neurones. Analogues of dequalinium possessing 3-6, 8, 10, and 12 methylene groups in the linking chain have been synthesized and tested for inhibition of the afterhyperpolarization in rat sympathetic neurones. The compounds having a 5-12-carbon chain showed very little variation in their activity as SKCa channel blockers. The analogues possessing four and three methylenes exhibited 3- and 8-fold lower potency, respectively, compared with dequalinium. These results are discussed in the context of possible modes of binding of the compounds to the SKCa channel.
No takes yet. Share an insight, caveat, or question.
Galanakis et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: